Catheter Precision Inc. has announced a private placement financing through a securities purchase agreement with certain accredited investors. The company will issue and sell a total of 392,608 shares of common stock at $1.43 per share, as well as 1,616.33 shares of newly designated Series C-1 Convertible Preferred Stock, initially convertible into up to 1,130,301 shares of common stock at the same conversion price. The private placement was conducted under an exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D. Dawson James Securities, Inc. acted as the exclusive placement agent for the financing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-003387), on February 06, 2026, and is solely responsible for the information contained therein.